Saltar al contenido principal
Elsevier

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

  • 1 Edición - 26 de enero de 2019
  • Última edición
  • Editor: Prashant Kesharwani
  • Idioma: Inglés

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and devel… Leer más

Descripción

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

Puntos claves

  • Provides an overview of an array of nanotechnology-based drug delivery systems
  • Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
  • Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers

De interès para

Pharmaceutical scientists, clinical researchers especially cancer researchers, biomedical and biotechnology professionals, graduate students and academic researchers in pharmaceutical science and materials science working in drug delivery and nanotechnology

Índice

PrefacePrashant Kesharwani1. Introduction: An Overview of the anatomy and physiology of the lungShadab Md2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug ResistanceChitra Thakur3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancerBapi Gorain4. Polymeric nanoparticles based drug delivery for lung cancerLipika Ray5. Solid lipid nanoparticles based drug delivery for lung cancerAhmed Elzoghby6. Liposomes and niosomes based drug delivery for lung cancerPaulina Skupin-Mrugalska7. Dendrimers based drug delivery for lung cancerPrashant Kesharwani8. Micelles based drug delivery for lung cancerKhaled Greish9. Nanoemulsions based drug delivery for lung cancerHira Choudhury10. Nanomedicine-based inhalation treatments for lung cancerRémi Rosière11. Towards development of novel diagnostic nano-imaging platform for lung cancerZahid Hussain12. Hydrogel based drug delivery for lung cancerVijay Mishra13. Quantum dots based drug delivery for lung cancerVijay Mishra

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 26 de enero de 2019
  • Idioma: Inglés

Sobre el editor

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Afiliaciones y experiencia
Dr. Harisingh Gour Vishwavidyalaya University, India

Ver libro en ScienceDirect

Lee Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer en ScienceDirect